{"gene":"AP2A2","run_date":"2026-06-09T22:02:43","timeline":{"discoveries":[{"year":2018,"finding":"LLO (Listeriolysin O) from Listeria monocytogenes interacts with AP2A2 via its PEST-like sequence at the inner face of the plasma membrane; AP2A2-dependent endocytosis is required to remove LLO puncta from the plasma membrane and prevent LLO-induced cytotoxicity. A heterologous PEST-like sequence from a human GPCR that also binds AP2A2 could functionally complement LLO's PEST-like sequence, demonstrating the interaction is PEST-sequence dependent.","method":"Co-immunoprecipitation, genetic knockdown of Ap2a2, cytotoxicity assays, functional complementation with heterologous PEST sequence","journal":"Cell host & microbe","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal functional assays, knockdown with specific phenotypic readout, complementation experiment, multiple orthogonal methods in one study","pmids":["29902442"],"is_preprint":false},{"year":2019,"finding":"Adipocyte-specific knockout of Ap2a2 impairs β-adrenergic receptor-stimulated lipolysis, evidenced by loss of cAMP response, reduced PKA activation, and decreased glycerol/fatty acid release. This is mechanistically linked to increased cell-surface retention of β2- and β3-adrenergic receptors, demonstrating that Ap2a2-dependent clathrin-mediated endocytosis is required for normal β-AR internalization and downstream lipolytic signaling. Ap2a2 was identified as a PPARα target gene, placing it downstream of PPARα in the regulation of adipose tissue lipolysis.","method":"Adipocyte-specific Ap2a2 knockout mice (loss-of-function), cAMP and PKA activation assays, glycerol/fatty acid release assays, cell-surface receptor quantification, metabolic phenotyping with PPARα agonist WY-14643","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean conditional KO with multiple orthogonal mechanistic readouts (receptor surface levels, cAMP, PKA, lipolysis outputs) in a single rigorous study","pmids":["31533003"],"is_preprint":false},{"year":2011,"finding":"AP2A2 functions as a positive regulator of hematopoietic stem cell (HSC) activity and undergoes asymmetric segregation during HSC/progenitor cytokinesis, consistent with a role as a fate determinant in asymmetric cell division. Overexpression/altered levels of Ap2a2 altered HSC fate in an in vitro-to-in vivo functional screen.","method":"In vitro to in vivo HSC functional screen, live-cell videomicroscopy of cytokinesis to detect asymmetric segregation","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — live imaging plus functional in vivo screen, but mechanism linking asymmetric segregation to fate determination is not fully resolved in the abstract","pmids":["22174158"],"is_preprint":false},{"year":2024,"finding":"A homozygous missense variant in AP2A2 causes hereditary spastic paraplegia (HSP) with corpus callosum thinning. Patient iPSC-derived neurons show reduced AP2A2 protein levels and decreased transferrin receptor endocytosis, directly linking AP2A2 loss-of-function to defective endocytosis in neurons. The mutant AP-2 α-appendage domain shows defective binding to accessory endocytic proteins by immunoprecipitation. ap2a2 knockout in Xenopus tropicalis tadpoles causes cerebral edema and progressive seizures.","method":"Whole exome sequencing, Western blot (patient iPSC-derived neurons), transferrin receptor endocytosis assay, immunoprecipitation of mutant AP-2 appendage domain, Xenopus ap2a2 knockout model","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (patient cells, endocytosis assay, binding assay with mutant construct, in vivo vertebrate KO) converging on AP2A2 loss causing defective endocytosis and neurological phenotype","pmids":["38772452"],"is_preprint":false},{"year":2021,"finding":"AP2A2 protein colocalizes specifically with microglial cells in human brain, while the paralog AP2A1 colocalizes with neurofibrillary tangles in Alzheimer's disease brains. AP2A2 (but not AP2A1) is enriched in the detergent-insoluble fraction from cognitively impaired brains. Antibody specificity was validated by immunoblot after transfection of AP2A1 and AP2A2 plasmids.","method":"Immunoblot with validated isoform-specific antibodies after plasmid transfection, immunohistochemistry, immunofluorescence with digital colocalization quantification, detergent-solubility fractionation of human brain tissue","journal":"Neuropathology and applied neurobiology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — validated antibody specificity plus multiple localization methods, but functional consequence of microglial localization is not directly tested","pmids":["34820873"],"is_preprint":false},{"year":2025,"finding":"AP-2 complex subunits Ap2a2, Ap2m1, and Ap2s1 are required for efficient intracellular replication of Listeria monocytogenes in macrophages and epithelial cells. CRISPR/Cas9 knockout of any single subunit markedly inhibits intracellular bacterial proliferation. Proteomic analysis confirmed functional cooperation among the three subunits during infection, and the role of AP-2 was shown to be in facilitating post-phagosomal cytosolic replication, independent of cell-to-cell bacterial spread.","method":"Proteomics of infected cells, CRISPR/Cas9 knockout of Ap2a2/Ap2m1/Ap2s1, intracellular bacterial proliferation assays in Raw264.7 macrophages, DC2.4 dendritic cells, HeLa and Caco-2 cells","journal":"Proteomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with specific phenotypic readout and proteomics, single lab study","pmids":["40847839"],"is_preprint":false},{"year":2025,"finding":"siRNA-mediated knockdown of Ap2a2 in Psen2-knockdown BV2 microglial cells impacted both cellular phenotypes and reversed AD-associated proteomic patterns, identifying Ap2a2 as a functionally validated Alzheimer's disease therapeutic target.","method":"siRNA knockdown, cellular phenotypic assays, quantitative proteomics in Psen2-knockdown murine BV2 microglial cells","journal":"Alzheimer's & dementia","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — clean KD with defined proteomic phenotype, but single lab and mechanistic detail is limited in the abstract","pmids":["41388808"],"is_preprint":false},{"year":2010,"finding":"AP2A2 was identified as part of the EGFR interactome by affinity purification-mass spectrometry; levels of AP2A2 (along with AP2A1 and AP2B1) were increased in erlotinib-resistant non-small cell lung cancer cells, suggesting AP-2-mediated EGFR endocytosis is altered in resistance.","method":"Affinity purification coupled with high-resolution mass spectrometry (EGFR interactome characterization)","journal":"European journal of pharmaceutical sciences","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single AP-MS experiment, no direct functional follow-up on AP2A2 specifically","pmids":["27112992"],"is_preprint":false},{"year":2020,"finding":"AP2A2 protein was identified as a novel interaction partner of cardiac syndecan-2 by affinity purification-mass spectrometry in rat left ventricle, and this interaction was verified in HEK293 cells.","method":"Affinity purification combined with mass spectrometry, verified in HEK293 cells","journal":"Frontiers in cell and developmental biology","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single AP-MS study with HEK293 verification, no functional consequence of the interaction determined","pmids":["32984315"],"is_preprint":false}],"current_model":"AP2A2 encodes the alpha-2 subunit of the AP-2 adaptor complex and functions as a core component of clathrin-mediated endocytosis: it mediates internalization of β-adrenergic receptors to enable lipolytic signaling in adipocytes, removes pore-forming toxin LLO from the plasma membrane during Listeria infection via PEST-sequence-dependent interaction, is required for transferrin receptor endocytosis in neurons (with loss-of-function causing hereditary spastic paraplegia and defective accessory-protein binding at the alpha-appendage domain), and facilitates intracellular Listeria replication in a post-phagosomal manner; in the brain it localizes specifically to microglial cells and accumulates in detergent-insoluble fractions in Alzheimer's disease."},"narrative":{"mechanistic_narrative":"AP2A2 encodes the alpha-2 subunit of the AP-2 adaptor complex and functions as a core component of clathrin-mediated endocytosis, selecting cargo for internalization at the plasma membrane through its appendage domain [PMID:38772452]. In adipocytes it drives β-adrenergic receptor internalization: loss of Ap2a2 retains β2- and β3-adrenergic receptors at the cell surface and impairs cAMP/PKA-driven lipolysis, placing it downstream of PPARα as a transcriptional target in adipose tissue [PMID:31533003]. Its endocytic function depends on recognition of PEST-like sorting determinants, exploited by the Listeria pore-forming toxin LLO, whose PEST-like sequence binds AP2A2 to drive its endocytic removal from the plasma membrane and limit cytotoxicity; this requirement is interchangeable with a heterologous GPCR PEST sequence [PMID:29902442]. The complete AP-2 complex (Ap2a2, Ap2m1, Ap2s1) is also required for post-phagosomal cytosolic replication of intracellular Listeria [PMID:40847839]. A homozygous missense variant in AP2A2 causes hereditary spastic paraplegia with corpus callosum thinning, acting through reduced protein levels and defective transferrin receptor endocytosis in patient iPSC-derived neurons, with the mutant α-appendage domain showing impaired binding to accessory endocytic proteins [PMID:38772452]. In the brain AP2A2 localizes to microglia and accumulates in the detergent-insoluble fraction of cognitively impaired brains, and its knockdown reverses Alzheimer-associated microglial proteomic phenotypes [PMID:34820873, PMID:41388808]. AP2A2 additionally undergoes asymmetric segregation during hematopoietic stem cell cytokinesis and acts as a positive regulator of HSC activity [PMID:22174158].","teleology":[{"year":2011,"claim":"Established AP2A2 as more than a housekeeping endocytic subunit by showing it is a fate-influencing factor that asymmetrically segregates during stem cell division.","evidence":"In vitro-to-in vivo HSC functional screen with live-cell videomicroscopy of cytokinesis","pmids":["22174158"],"confidence":"Medium","gaps":["Mechanism linking asymmetric AP2A2 segregation to fate determination not resolved","No connection drawn to its endocytic role","No molecular partners identified in this context"]},{"year":2018,"claim":"Defined the cargo-recognition logic of AP2A2 by showing it binds PEST-like sorting sequences, here used by the Listeria toxin LLO to be cleared from the plasma membrane.","evidence":"Co-IP, Ap2a2 knockdown with cytotoxicity readout, and functional complementation with a heterologous GPCR PEST sequence","pmids":["29902442"],"confidence":"High","gaps":["Structural basis of PEST recognition by the appendage domain not defined","Endogenous mammalian PEST-bearing cargo not enumerated"]},{"year":2019,"claim":"Demonstrated a physiological cargo and pathway by showing AP2A2 internalizes β-adrenergic receptors to sustain lipolytic signaling, and placed it transcriptionally downstream of PPARα.","evidence":"Adipocyte-specific Ap2a2 knockout mice with cAMP/PKA, lipolysis, and surface receptor assays plus PPARα agonist phenotyping","pmids":["31533003"],"confidence":"High","gaps":["Direct AP2A2–β-AR contact not structurally mapped","Whether PPARα regulation is direct (promoter binding) not shown"]},{"year":2021,"claim":"Distinguished AP2A2 from its paralog AP2A1 in the diseased brain, localizing AP2A2 to microglia and to the detergent-insoluble fraction of cognitively impaired tissue.","evidence":"Isoform-specific validated antibodies, immunohistochemistry/immunofluorescence with colocalization, and detergent-solubility fractionation of human brain","pmids":["34820873"],"confidence":"Medium","gaps":["Functional consequence of microglial localization not tested","Cause of detergent-insolubility (aggregation vs. complex assembly) unknown"]},{"year":2024,"claim":"Causally linked AP2A2 loss-of-function to human neurological disease, tying a missense variant to defective neuronal endocytosis via impaired appendage-domain binding.","evidence":"Whole exome sequencing, patient iPSC-derived neuron Western blot and transferrin receptor endocytosis assay, mutant appendage-domain IP, and Xenopus ap2a2 knockout","pmids":["38772452"],"confidence":"High","gaps":["Specific accessory proteins lost from mutant appendage not all identified","Cell type driving the spastic paraplegia phenotype not pinpointed"]},{"year":2025,"claim":"Showed the intact AP-2 complex is co-opted for intracellular Listeria replication at a post-phagosomal cytosolic step, distinct from earlier toxin-clearance role.","evidence":"Proteomics and CRISPR/Cas9 knockout of Ap2a2/Ap2m1/Ap2s1 with intracellular proliferation assays across macrophage, dendritic, and epithelial lines","pmids":["40847839"],"confidence":"Medium","gaps":["Molecular target of AP-2 during cytosolic replication unknown","Reconciliation with the protective LLO-clearance role not addressed","Single-lab study"]},{"year":2025,"claim":"Functionally validated AP2A2 as an Alzheimer's disease microglial target by showing its knockdown reverses AD-associated proteomic signatures.","evidence":"siRNA knockdown with cellular phenotype and quantitative proteomics in Psen2-knockdown BV2 microglia","pmids":["41388808"],"confidence":"Medium","gaps":["Mechanistic link between AP2A2 and AD proteomic changes not defined","In vivo validation absent","Single-lab study"]},{"year":null,"claim":"How a single endocytic adaptor subunit reconciles its roles across receptor internalization, toxin clearance, pathogen exploitation, stem cell fate, and neurodegeneration remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of AP2A2 cargo/accessory-protein recognition in the timeline","Tissue-specific cargo repertoire incompletely mapped","Mechanism connecting microglial AP2A2 to AD pathology unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1,3]},{"term_id":"GO:0038024","term_label":"cargo receptor activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,1,3]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[1]}],"complexes":["AP-2 adaptor complex"],"partners":["AP2M1","AP2S1","EGFR","SDC2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O94973","full_name":"AP-2 complex subunit alpha-2","aliases":["100 kDa coated vesicle protein C","Adaptor protein complex AP-2 subunit alpha-2","Adaptor-related protein complex 2 subunit alpha-2","Alpha-adaptin C","Alpha2-adaptin","Clathrin assembly protein complex 2 alpha-C large chain","Huntingtin yeast partner J","Huntingtin-interacting protein 9","HIP-9","Huntingtin-interacting protein J","Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit"],"length_aa":939,"mass_kda":104.0,"function":"Component of the adaptor protein complex 2 (AP-2). Adaptor protein complexes function in protein transport via transport vesicles in different membrane traffic pathways. Adaptor protein complexes are vesicle coat components and appear to be involved in cargo selection and vesicle formation. AP-2 is involved in clathrin-dependent endocytosis in which cargo proteins are incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with the early endosome. The clathrin lattice serves as a mechanical scaffold but is itself unable to bind directly to membrane components. Clathrin-associated adaptor protein (AP) complexes which can bind directly to both the clathrin lattice and to the lipid and protein components of membranes are considered to be the major clathrin adaptors contributing the CCV formation. AP-2 also serves as a cargo receptor to selectively sort the membrane proteins involved in receptor-mediated endocytosis. AP-2 seems to play a role in the recycling of synaptic vesicle membranes from the presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi) and [ED]-X-X-X-L-[LI] endocytosis signal motifs within the cytosolic tails of transmembrane cargo molecules. AP-2 may also play a role in maintaining normal post-endocytic trafficking through the ARF6-regulated, non-clathrin pathway. During long-term potentiation in hippocampal neurons, AP-2 is responsible for the endocytosis of ADAM10 (PubMed:23676497). The AP-2 alpha subunit binds polyphosphoinositide-containing lipids, positioning AP-2 on the membrane. The AP-2 alpha subunit acts via its C-terminal appendage domain as a scaffolding platform for endocytic accessory proteins. The AP-2 alpha and AP-2 sigma subunits are thought to contribute to the recognition of the [ED]-X-X-X-L-[LI] motif (By similarity)","subcellular_location":"Cell membrane; Membrane, coated pit","url":"https://www.uniprot.org/uniprotkb/O94973/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/AP2A2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"AP2B1","stoichiometry":10.0},{"gene":"AP2S1","stoichiometry":10.0},{"gene":"ANKRD28","stoichiometry":0.2},{"gene":"CALD1","stoichiometry":0.2},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"CLTA","stoichiometry":0.2},{"gene":"CLTB","stoichiometry":0.2},{"gene":"EPS15","stoichiometry":0.2},{"gene":"NECAP1","stoichiometry":0.2},{"gene":"NECAP2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/AP2A2","total_profiled":1310},"omim":[{"mim_id":"607242","title":"ADAPTOR-RELATED PROTEIN COMPLEX 2, ALPHA-2 SUBUNIT; AP2A2","url":"https://www.omim.org/entry/607242"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":50.3}],"url":"https://www.proteinatlas.org/search/AP2A2"},"hgnc":{"alias_symbol":["DKFZP564D1864","HYPJ","KIAA0899","HIP9"],"prev_symbol":["CLAPA2","ADTAB"]},"alphafold":{"accession":"O94973","domains":[{"cath_id":"-","chopping":"10-82","consensus_level":"medium","plddt":89.9422,"start":10,"end":82},{"cath_id":"2.60.40.1230","chopping":"703-822","consensus_level":"high","plddt":91.6042,"start":703,"end":822},{"cath_id":"3.30.310.10","chopping":"825-938","consensus_level":"high","plddt":90.6367,"start":825,"end":938}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O94973","model_url":"https://alphafold.ebi.ac.uk/files/AF-O94973-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O94973-F1-predicted_aligned_error_v6.png","plddt_mean":84.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=AP2A2","jax_strain_url":"https://www.jax.org/strain/search?query=AP2A2"},"sequence":{"accession":"O94973","fasta_url":"https://rest.uniprot.org/uniprotkb/O94973.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O94973/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O94973"}},"corpus_meta":[{"pmid":"22174158","id":"PMC_22174158","title":"Asymmetric segregation and self-renewal of hematopoietic stem and progenitor cells with endocytic Ap2a2.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/22174158","citation_count":70,"is_preprint":false},{"pmid":"29046734","id":"PMC_29046734","title":"Epigenome-wide association study of asthma and wheeze in childhood and adolescence.","date":"2017","source":"Clinical epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/29046734","citation_count":59,"is_preprint":false},{"pmid":"25241909","id":"PMC_25241909","title":"Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease.","date":"2014","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/25241909","citation_count":45,"is_preprint":false},{"pmid":"29902442","id":"PMC_29902442","title":"The Listeriolysin O PEST-like Sequence Co-opts AP-2-Mediated Endocytosis to Prevent Plasma Membrane Damage during Listeria Infection.","date":"2018","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/29902442","citation_count":42,"is_preprint":false},{"pmid":"31748784","id":"PMC_31748784","title":"Alzheimer Disease Pathology-Associated Polymorphism in a Complex Variable Number of Tandem Repeat Region Within the MUC6 Gene, Near the AP2A2 Gene.","date":"2020","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31748784","citation_count":26,"is_preprint":false},{"pmid":"32357373","id":"PMC_32357373","title":"The MUC6/AP2A2 Locus and Its Relevance to Alzheimer's Disease: A Review.","date":"2020","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32357373","citation_count":25,"is_preprint":false},{"pmid":"33028190","id":"PMC_33028190","title":"DNA methylation microarrays identify epigenetically regulated lipid related genes in obese patients with hypercholesterolemia.","date":"2020","source":"Molecular medicine (Cambridge, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/33028190","citation_count":22,"is_preprint":false},{"pmid":"31533003","id":"PMC_31533003","title":"The role of Ap2a2 in PPARα-mediated regulation of lipolysis in adipose tissue.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31533003","citation_count":21,"is_preprint":false},{"pmid":"29685964","id":"PMC_29685964","title":"In silico epigenetics of metal exposure and subclinical atherosclerosis in middle aged men: pilot results from the Aragon Workers Health Study.","date":"2018","source":"Philosophical transactions of the Royal Society of London. Series B, Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29685964","citation_count":21,"is_preprint":false},{"pmid":"27112992","id":"PMC_27112992","title":"Utilising the EGFR interactome to identify mechanisms of drug resistance in non-small cell lung cancer - Proof of concept towards a systems pharmacology approach.","date":"2016","source":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/27112992","citation_count":21,"is_preprint":false},{"pmid":"3941206","id":"PMC_3941206","title":"Characterization of retrograde conduction by direct endocardial recording from an accessory atrioventricular pathway.","date":"1986","source":"Journal of the American College of Cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/3941206","citation_count":20,"is_preprint":false},{"pmid":"29532581","id":"PMC_29532581","title":"Genome-wide association study in Finnish twins highlights the connection between nicotine addiction and neurotrophin signaling pathway.","date":"2018","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/29532581","citation_count":19,"is_preprint":false},{"pmid":"35299244","id":"PMC_35299244","title":"Blood DNA Methylation Patterns in Older Adults With Evolving Dementia.","date":"2022","source":"The journals of gerontology. Series A, Biological sciences and medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35299244","citation_count":16,"is_preprint":false},{"pmid":"34820873","id":"PMC_34820873","title":"Alpha adaptins show isoform-specific association with neurofibrillary tangles in Alzheimer's disease.","date":"2021","source":"Neuropathology and applied neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/34820873","citation_count":15,"is_preprint":false},{"pmid":"33649539","id":"PMC_33649539","title":"Lung expression of genes putatively involved in SARS-CoV-2 infection is modulated in cis by germline variants.","date":"2021","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/33649539","citation_count":15,"is_preprint":false},{"pmid":"30463235","id":"PMC_30463235","title":"Association of Candidate Genes with Response to Heat and Newcastle Disease Virus.","date":"2018","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/30463235","citation_count":14,"is_preprint":false},{"pmid":"23811784","id":"PMC_23811784","title":"The effect of clozapine on mRNA expression for genes encoding G protein-coupled receptors and the protein components of clathrin-mediated endocytosis.","date":"2013","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23811784","citation_count":11,"is_preprint":false},{"pmid":"28800327","id":"PMC_28800327","title":"Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data.","date":"2017","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/28800327","citation_count":11,"is_preprint":false},{"pmid":"32478689","id":"PMC_32478689","title":"Possible key microRNAs and corresponding molecular mechanisms for atrial fibrillation.","date":"2020","source":"Anatolian journal of cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/32478689","citation_count":10,"is_preprint":false},{"pmid":"38295386","id":"PMC_38295386","title":"An Insulin-Chromogranin A Hybrid Peptide Activates DR11-Restricted T Cells in Human Type 1 Diabetes.","date":"2024","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/38295386","citation_count":9,"is_preprint":false},{"pmid":"32984315","id":"PMC_32984315","title":"The Cardiac Syndecan-2 Interactome.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/32984315","citation_count":7,"is_preprint":false},{"pmid":"30086706","id":"PMC_30086706","title":"A genetic variant near adaptor-related protein complex 2 alpha 2 subunit gene is associated with coronary artery disease in a Chinese population.","date":"2018","source":"BMC cardiovascular disorders","url":"https://pubmed.ncbi.nlm.nih.gov/30086706","citation_count":6,"is_preprint":false},{"pmid":"38772452","id":"PMC_38772452","title":"AP2A2 mutation and defective endocytosis in a Malian family with hereditary spastic paraplegia.","date":"2024","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/38772452","citation_count":5,"is_preprint":false},{"pmid":"37747672","id":"PMC_37747672","title":"Exploring the Synergistic Mechanism of AP2A2 Transcription Factor Inhibition via Molecular Modeling and Simulations as a Novel Computational Approach for Combating Breast Cancer: In Silico Interpretations.","date":"2023","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/37747672","citation_count":5,"is_preprint":false},{"pmid":"36946148","id":"PMC_36946148","title":"Genetic analyses of chr11p15.5 region identify MUC5AC-MUC5B associated with asthma-related phenotypes.","date":"2023","source":"The Journal of asthma : official journal of the Association for the Care of Asthma","url":"https://pubmed.ncbi.nlm.nih.gov/36946148","citation_count":4,"is_preprint":false},{"pmid":"38990251","id":"PMC_38990251","title":"Synaptic Vesicle-Related Proteins and Ubiquilin 2 in Cortical Synaptosomes Mediate Cognitive Impairment in Vascular Dementia Rats.","date":"2024","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/38990251","citation_count":3,"is_preprint":false},{"pmid":"38806002","id":"PMC_38806002","title":"Genome-wide association study reveals the candidate genes of humerus quality in laying duck.","date":"2024","source":"Poultry science","url":"https://pubmed.ncbi.nlm.nih.gov/38806002","citation_count":3,"is_preprint":false},{"pmid":"39927718","id":"PMC_39927718","title":"Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis.","date":"2025","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39927718","citation_count":2,"is_preprint":false},{"pmid":"40847839","id":"PMC_40847839","title":"Proteomics Reveals AP-2 Complex Depletion Suppressing Listeria monocytogenes Intracellular Replication.","date":"2025","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/40847839","citation_count":1,"is_preprint":false},{"pmid":"41388808","id":"PMC_41388808","title":"Integrated phenotypic and proteomic screening identifies top-tier Alzheimer's disease therapeutic targets.","date":"2025","source":"Alzheimer's & dementia : the journal of the Alzheimer's Association","url":"https://pubmed.ncbi.nlm.nih.gov/41388808","citation_count":1,"is_preprint":false},{"pmid":"39547361","id":"PMC_39547361","title":"Genetic and epigenetic factors affecting carotid intima-media thickness in monozygotic twins.","date":"2024","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/39547361","citation_count":0,"is_preprint":false},{"pmid":"41592030","id":"PMC_41592030","title":"Unveiling the molecular mechanisms of burn injury through integrated single-cell and bulk transcriptomic analysis.","date":"2026","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/41592030","citation_count":0,"is_preprint":false},{"pmid":"41818416","id":"PMC_41818416","title":"Epigenetic Alterations Beyond CpG Islands in Periodontitis: In Silico Study of DNA Methylation Data.","date":"2026","source":"Clinical and experimental dental research","url":"https://pubmed.ncbi.nlm.nih.gov/41818416","citation_count":0,"is_preprint":false},{"pmid":"41278819","id":"PMC_41278819","title":"Integrated phenotypic and proteomic screening identifies top-tier Alzheimer's disease therapeutic targets.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41278819","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.16.682926","title":"Integrated phenotypic and proteomic screening identifies top-tier Alzheimer’s disease therapeutic targets","date":"2025-10-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.16.682926","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21619,"output_tokens":2628,"usd":0.052138,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9845,"output_tokens":2919,"usd":0.0611,"stage2_stop_reason":"end_turn"},"total_usd":0.113238,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2018,\n      \"finding\": \"LLO (Listeriolysin O) from Listeria monocytogenes interacts with AP2A2 via its PEST-like sequence at the inner face of the plasma membrane; AP2A2-dependent endocytosis is required to remove LLO puncta from the plasma membrane and prevent LLO-induced cytotoxicity. A heterologous PEST-like sequence from a human GPCR that also binds AP2A2 could functionally complement LLO's PEST-like sequence, demonstrating the interaction is PEST-sequence dependent.\",\n      \"method\": \"Co-immunoprecipitation, genetic knockdown of Ap2a2, cytotoxicity assays, functional complementation with heterologous PEST sequence\",\n      \"journal\": \"Cell host & microbe\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal functional assays, knockdown with specific phenotypic readout, complementation experiment, multiple orthogonal methods in one study\",\n      \"pmids\": [\"29902442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Adipocyte-specific knockout of Ap2a2 impairs β-adrenergic receptor-stimulated lipolysis, evidenced by loss of cAMP response, reduced PKA activation, and decreased glycerol/fatty acid release. This is mechanistically linked to increased cell-surface retention of β2- and β3-adrenergic receptors, demonstrating that Ap2a2-dependent clathrin-mediated endocytosis is required for normal β-AR internalization and downstream lipolytic signaling. Ap2a2 was identified as a PPARα target gene, placing it downstream of PPARα in the regulation of adipose tissue lipolysis.\",\n      \"method\": \"Adipocyte-specific Ap2a2 knockout mice (loss-of-function), cAMP and PKA activation assays, glycerol/fatty acid release assays, cell-surface receptor quantification, metabolic phenotyping with PPARα agonist WY-14643\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean conditional KO with multiple orthogonal mechanistic readouts (receptor surface levels, cAMP, PKA, lipolysis outputs) in a single rigorous study\",\n      \"pmids\": [\"31533003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"AP2A2 functions as a positive regulator of hematopoietic stem cell (HSC) activity and undergoes asymmetric segregation during HSC/progenitor cytokinesis, consistent with a role as a fate determinant in asymmetric cell division. Overexpression/altered levels of Ap2a2 altered HSC fate in an in vitro-to-in vivo functional screen.\",\n      \"method\": \"In vitro to in vivo HSC functional screen, live-cell videomicroscopy of cytokinesis to detect asymmetric segregation\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — live imaging plus functional in vivo screen, but mechanism linking asymmetric segregation to fate determination is not fully resolved in the abstract\",\n      \"pmids\": [\"22174158\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"A homozygous missense variant in AP2A2 causes hereditary spastic paraplegia (HSP) with corpus callosum thinning. Patient iPSC-derived neurons show reduced AP2A2 protein levels and decreased transferrin receptor endocytosis, directly linking AP2A2 loss-of-function to defective endocytosis in neurons. The mutant AP-2 α-appendage domain shows defective binding to accessory endocytic proteins by immunoprecipitation. ap2a2 knockout in Xenopus tropicalis tadpoles causes cerebral edema and progressive seizures.\",\n      \"method\": \"Whole exome sequencing, Western blot (patient iPSC-derived neurons), transferrin receptor endocytosis assay, immunoprecipitation of mutant AP-2 appendage domain, Xenopus ap2a2 knockout model\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (patient cells, endocytosis assay, binding assay with mutant construct, in vivo vertebrate KO) converging on AP2A2 loss causing defective endocytosis and neurological phenotype\",\n      \"pmids\": [\"38772452\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"AP2A2 protein colocalizes specifically with microglial cells in human brain, while the paralog AP2A1 colocalizes with neurofibrillary tangles in Alzheimer's disease brains. AP2A2 (but not AP2A1) is enriched in the detergent-insoluble fraction from cognitively impaired brains. Antibody specificity was validated by immunoblot after transfection of AP2A1 and AP2A2 plasmids.\",\n      \"method\": \"Immunoblot with validated isoform-specific antibodies after plasmid transfection, immunohistochemistry, immunofluorescence with digital colocalization quantification, detergent-solubility fractionation of human brain tissue\",\n      \"journal\": \"Neuropathology and applied neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — validated antibody specificity plus multiple localization methods, but functional consequence of microglial localization is not directly tested\",\n      \"pmids\": [\"34820873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"AP-2 complex subunits Ap2a2, Ap2m1, and Ap2s1 are required for efficient intracellular replication of Listeria monocytogenes in macrophages and epithelial cells. CRISPR/Cas9 knockout of any single subunit markedly inhibits intracellular bacterial proliferation. Proteomic analysis confirmed functional cooperation among the three subunits during infection, and the role of AP-2 was shown to be in facilitating post-phagosomal cytosolic replication, independent of cell-to-cell bacterial spread.\",\n      \"method\": \"Proteomics of infected cells, CRISPR/Cas9 knockout of Ap2a2/Ap2m1/Ap2s1, intracellular bacterial proliferation assays in Raw264.7 macrophages, DC2.4 dendritic cells, HeLa and Caco-2 cells\",\n      \"journal\": \"Proteomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with specific phenotypic readout and proteomics, single lab study\",\n      \"pmids\": [\"40847839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"siRNA-mediated knockdown of Ap2a2 in Psen2-knockdown BV2 microglial cells impacted both cellular phenotypes and reversed AD-associated proteomic patterns, identifying Ap2a2 as a functionally validated Alzheimer's disease therapeutic target.\",\n      \"method\": \"siRNA knockdown, cellular phenotypic assays, quantitative proteomics in Psen2-knockdown murine BV2 microglial cells\",\n      \"journal\": \"Alzheimer's & dementia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — clean KD with defined proteomic phenotype, but single lab and mechanistic detail is limited in the abstract\",\n      \"pmids\": [\"41388808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"AP2A2 was identified as part of the EGFR interactome by affinity purification-mass spectrometry; levels of AP2A2 (along with AP2A1 and AP2B1) were increased in erlotinib-resistant non-small cell lung cancer cells, suggesting AP-2-mediated EGFR endocytosis is altered in resistance.\",\n      \"method\": \"Affinity purification coupled with high-resolution mass spectrometry (EGFR interactome characterization)\",\n      \"journal\": \"European journal of pharmaceutical sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single AP-MS experiment, no direct functional follow-up on AP2A2 specifically\",\n      \"pmids\": [\"27112992\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"AP2A2 protein was identified as a novel interaction partner of cardiac syndecan-2 by affinity purification-mass spectrometry in rat left ventricle, and this interaction was verified in HEK293 cells.\",\n      \"method\": \"Affinity purification combined with mass spectrometry, verified in HEK293 cells\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single AP-MS study with HEK293 verification, no functional consequence of the interaction determined\",\n      \"pmids\": [\"32984315\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"AP2A2 encodes the alpha-2 subunit of the AP-2 adaptor complex and functions as a core component of clathrin-mediated endocytosis: it mediates internalization of β-adrenergic receptors to enable lipolytic signaling in adipocytes, removes pore-forming toxin LLO from the plasma membrane during Listeria infection via PEST-sequence-dependent interaction, is required for transferrin receptor endocytosis in neurons (with loss-of-function causing hereditary spastic paraplegia and defective accessory-protein binding at the alpha-appendage domain), and facilitates intracellular Listeria replication in a post-phagosomal manner; in the brain it localizes specifically to microglial cells and accumulates in detergent-insoluble fractions in Alzheimer's disease.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"AP2A2 encodes the alpha-2 subunit of the AP-2 adaptor complex and functions as a core component of clathrin-mediated endocytosis, selecting cargo for internalization at the plasma membrane through its appendage domain [#3]. In adipocytes it drives β-adrenergic receptor internalization: loss of Ap2a2 retains β2- and β3-adrenergic receptors at the cell surface and impairs cAMP/PKA-driven lipolysis, placing it downstream of PPARα as a transcriptional target in adipose tissue [#1]. Its endocytic function depends on recognition of PEST-like sorting determinants, exploited by the Listeria pore-forming toxin LLO, whose PEST-like sequence binds AP2A2 to drive its endocytic removal from the plasma membrane and limit cytotoxicity; this requirement is interchangeable with a heterologous GPCR PEST sequence [#0]. The complete AP-2 complex (Ap2a2, Ap2m1, Ap2s1) is also required for post-phagosomal cytosolic replication of intracellular Listeria [#5]. A homozygous missense variant in AP2A2 causes hereditary spastic paraplegia with corpus callosum thinning, acting through reduced protein levels and defective transferrin receptor endocytosis in patient iPSC-derived neurons, with the mutant α-appendage domain showing impaired binding to accessory endocytic proteins [#3]. In the brain AP2A2 localizes to microglia and accumulates in the detergent-insoluble fraction of cognitively impaired brains, and its knockdown reverses Alzheimer-associated microglial proteomic phenotypes [#4, #6]. AP2A2 additionally undergoes asymmetric segregation during hematopoietic stem cell cytokinesis and acts as a positive regulator of HSC activity [#2].\",\n  \"teleology\": [\n    {\n      \"year\": 2011,\n      \"claim\": \"Established AP2A2 as more than a housekeeping endocytic subunit by showing it is a fate-influencing factor that asymmetrically segregates during stem cell division.\",\n      \"evidence\": \"In vitro-to-in vivo HSC functional screen with live-cell videomicroscopy of cytokinesis\",\n      \"pmids\": [\"22174158\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism linking asymmetric AP2A2 segregation to fate determination not resolved\", \"No connection drawn to its endocytic role\", \"No molecular partners identified in this context\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the cargo-recognition logic of AP2A2 by showing it binds PEST-like sorting sequences, here used by the Listeria toxin LLO to be cleared from the plasma membrane.\",\n      \"evidence\": \"Co-IP, Ap2a2 knockdown with cytotoxicity readout, and functional complementation with a heterologous GPCR PEST sequence\",\n      \"pmids\": [\"29902442\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Structural basis of PEST recognition by the appendage domain not defined\", \"Endogenous mammalian PEST-bearing cargo not enumerated\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated a physiological cargo and pathway by showing AP2A2 internalizes β-adrenergic receptors to sustain lipolytic signaling, and placed it transcriptionally downstream of PPARα.\",\n      \"evidence\": \"Adipocyte-specific Ap2a2 knockout mice with cAMP/PKA, lipolysis, and surface receptor assays plus PPARα agonist phenotyping\",\n      \"pmids\": [\"31533003\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct AP2A2–β-AR contact not structurally mapped\", \"Whether PPARα regulation is direct (promoter binding) not shown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Distinguished AP2A2 from its paralog AP2A1 in the diseased brain, localizing AP2A2 to microglia and to the detergent-insoluble fraction of cognitively impaired tissue.\",\n      \"evidence\": \"Isoform-specific validated antibodies, immunohistochemistry/immunofluorescence with colocalization, and detergent-solubility fractionation of human brain\",\n      \"pmids\": [\"34820873\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Functional consequence of microglial localization not tested\", \"Cause of detergent-insolubility (aggregation vs. complex assembly) unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Causally linked AP2A2 loss-of-function to human neurological disease, tying a missense variant to defective neuronal endocytosis via impaired appendage-domain binding.\",\n      \"evidence\": \"Whole exome sequencing, patient iPSC-derived neuron Western blot and transferrin receptor endocytosis assay, mutant appendage-domain IP, and Xenopus ap2a2 knockout\",\n      \"pmids\": [\"38772452\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Specific accessory proteins lost from mutant appendage not all identified\", \"Cell type driving the spastic paraplegia phenotype not pinpointed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Showed the intact AP-2 complex is co-opted for intracellular Listeria replication at a post-phagosomal cytosolic step, distinct from earlier toxin-clearance role.\",\n      \"evidence\": \"Proteomics and CRISPR/Cas9 knockout of Ap2a2/Ap2m1/Ap2s1 with intracellular proliferation assays across macrophage, dendritic, and epithelial lines\",\n      \"pmids\": [\"40847839\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Molecular target of AP-2 during cytosolic replication unknown\", \"Reconciliation with the protective LLO-clearance role not addressed\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Functionally validated AP2A2 as an Alzheimer's disease microglial target by showing its knockdown reverses AD-associated proteomic signatures.\",\n      \"evidence\": \"siRNA knockdown with cellular phenotype and quantitative proteomics in Psen2-knockdown BV2 microglia\",\n      \"pmids\": [\"41388808\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanistic link between AP2A2 and AD proteomic changes not defined\", \"In vivo validation absent\", \"Single-lab study\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single endocytic adaptor subunit reconciles its roles across receptor internalization, toxin clearance, pathogen exploitation, stem cell fate, and neurodegeneration remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No structural model of AP2A2 cargo/accessory-protein recognition in the timeline\", \"Tissue-specific cargo repertoire incompletely mapped\", \"Mechanism connecting microglial AP2A2 to AD pathology unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"GO:0038024\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 1, 3]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [\"AP-2 adaptor complex\"],\n    \"partners\": [\"AP2M1\", \"AP2S1\", \"EGFR\", \"SDC2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}